Coagulopathy screening in children with heparinized central venous catheters.
OBJECTIVE
To develop a method of screening for coagulopathy using blood drawn through heparinized central venous catheters.


METHODS
Prothrombin time (PT) and activated partial thromboplastin time (APTT) were determined in paired blood samples with and without the addition of protamine, using an automated photo-optical method. A concentration of 4 micrograms/mL of citrated whole blood was chosen, based on preliminary experiments. This is sufficient to neutralize the expected heparin contamination in samples drawn through heparinized catheters while causing only a slight prolongation in APTT (due to the anticoagulant effect of protamine). Seventeen paired samples were drawn by venipuncture in patients without known coagulopathy. Twenty-five samples were drawn through heparinized central venous catheters. The first 5 mL of blood drawn from a catheter was discarded to avoid gross heparin contamination. Four samples from patients with coagulopathy were also analyzed with and without the addition of 2.5 micrograms/mL of heparin.


RESULTS
Protamine increased PT by 9.0 +/- 0.8% and APTT by 9.0 +/- 3.4% (mean +/- SD) in the samples drawn by venipuncture. For samples drawn through heparinized catheters, 52% had a prolonged APTT, 44% a prolonged PT, and 68% had at least one prolonged test. With the addition of protamine, and after correction for the 9% mean increase in PT and APTT, 4% of samples had a prolonged APTT, 12% had a prolonged PT, and 16% had at least one prolonged test (P = .00006, .014, and .0001). All four samples from patients with coagulopathy were correctly identified as abnormal after the addition of protamine, with or without added heparin.


CONCLUSIONS
A protamine-supplemented APTT test on blood drawn through a heparinized catheter may be an adequate screening test for coagulopathy. This procedure reduces discomfort in patients with an indwelling catheter by avoiding venipuncture.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.
M R
MR
Ellis
D016477:Artifacts; D001777:Blood Coagulation / Q000187:drug effects*; D001778:Blood Coagulation Disorders / Q000097:blood* / Q000175:diagnosis; D002405:Catheterization, Central Venous; D002408:Catheters, Indwelling; D002648:Child; D006493:Heparin / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D010314:Partial Thromboplastin Time; D011479:Protamines / Q000494:pharmacology*; D011517:Prothrombin Time
D011479:Protamines; D006493:Heparin